108 related articles for article (PubMed ID: 4027754)
21. Enzymological and morphological changes in rat intestinal mucosa following treatment with alkylating sugar alcohol derivatives.
Prajda N; Kralovánszky J; Kerpel-Fronius S; Gál F; Szentirmay Z
Anticancer Res; 1985; 5(4):451-6. PubMed ID: 4037742
[TBL] [Abstract][Full Text] [Related]
22. Neurite outgrowth and cell cycle kinetic changes induced by cis-diamminedichloroplatinum II and retinoic acid in a human neuroblastoma cell line.
Di Martino D; Avignolo C; Marsano B; Di Vinci A; Cara A; Giaretti W; Tonini GP
Cancer Lett; 1990 Jul; 52(2):101-6. PubMed ID: 2379134
[TBL] [Abstract][Full Text] [Related]
23. Enhanced cell killing through the use of cell kinetics-directed treatment schedules for two-drug combinations in vitro.
Barranco SC; May JT; Boerwinkle W; Nichols S; Hokanson KM; Schumann J; Göhde W; Bryant J; Guseman LF
Cancer Res; 1982 Jul; 42(7):2894-8. PubMed ID: 6177399
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of bone marrow in a patient with resistant neuroblastoma.
Helson L; Traganos F; Miller D
Cancer Clin Trials; 1981; 4(4):415-21. PubMed ID: 7318124
[TBL] [Abstract][Full Text] [Related]
25. [The effect of 3,4-disuccinyldianhydrogalactitol, N-nitrosourea and their combination on DNA synthesis in normal and mouse P388 tumor cells].
Sokolova IS; Veres Z; Jakus J; Otvos LL; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1989; (4):527-33. PubMed ID: 2794230
[TBL] [Abstract][Full Text] [Related]
26. Development and some characteristics of a P388 leukemia strain resistant to 1, 2:5, 6-dianhydrogalactitol.
Bence J; Somfai-Relle S; Gáti E
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):773-80. PubMed ID: 3770035
[TBL] [Abstract][Full Text] [Related]
27. Effect of an irradiated Escherichia coli endotoxin reparation on the sensitivity to a lymphotropic cytostatic agent in germfree and conventional mice.
Anderlik P; Szeri I; Bános Z; Wessely M; Bertók L; Radnai B
Acta Microbiol Hung; 1983; 30(3-4):239-45. PubMed ID: 6372357
[TBL] [Abstract][Full Text] [Related]
28. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
Eagan RT; Creagan ET; Bisel HF; Layton DD; Groover RV; Herman RC
Oncology; 1981; 38(1):4-6. PubMed ID: 7443176
[TBL] [Abstract][Full Text] [Related]
29. Synchronization effect of cis-dichlorodiammineplatinum on a human neuroblastoma in vitro and in nude mice.
Yokomori K; Tsuchida Y; Saito S; Yamamoto H; Takakura K; Nomura K
Gan; 1983 Dec; 74(6):902-10. PubMed ID: 6686824
[TBL] [Abstract][Full Text] [Related]
30. Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.
Institóris E; Tamás J
Biochem J; 1980 Mar; 185(3):659-66. PubMed ID: 7387628
[TBL] [Abstract][Full Text] [Related]
31. [MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
Wakabayashi T; Yoshida J; Inoue I; Kageyama N; Nagata M; Kanzaki M
Gan To Kagaku Ryoho; 1984 May; 11(5):1098-106. PubMed ID: 6586113
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.
Nakata B; Chung YS; Yokomatsu H; Sawada T; Kubo T; Kondo Y; Satake K; Sowa M
Jpn J Cancer Res; 1992 May; 83(5):477-82. PubMed ID: 1618697
[TBL] [Abstract][Full Text] [Related]
33. In vivo study on alkylation site in DNA by the bifunctional dianhydrogalactitol.
Institoris E
Chem Biol Interact; 1981 May; 35(2):207-16. PubMed ID: 7214602
[TBL] [Abstract][Full Text] [Related]
34. Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
Eagan RT; Childs DS; Layton DD; Laws ER; Bisel HF; Holbrook MA; Fleming TR
JAMA; 1979 May; 241(19):2046-50. PubMed ID: 219269
[TBL] [Abstract][Full Text] [Related]
35. [Etoposide effect on cell cycle kinetics of a human lung cancer cell line].
Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Inoue S; Kawakami Y; Mizuno S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1237-43. PubMed ID: 6732252
[TBL] [Abstract][Full Text] [Related]
36. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
Haas CD; Baker L; Thigpen T
Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
[No Abstract] [Full Text] [Related]
38. Phase II study of dianhydrogalactitol in malignant glioma.
Espana P; Wiernik PH; Walker MD
Cancer Treat Rep; 1978 Aug; 62(8):1199-200. PubMed ID: 210944
[No Abstract] [Full Text] [Related]
39. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
Thigpen JT; Al-Sarraf M; Hewlett JS
Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
[TBL] [Abstract][Full Text] [Related]
40. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
Stehman FB; Blessing JA; Delgado G; Louka M
Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
